Market Cap (In USD)
14.06 Million
Revenue (In USD)
324.23 Million
Net Income (In USD)
-83.06 Million
Avg. Volume
132.75 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.125-2.5
- PE
- -
- EPS
- -
- Beta Value
- 0.616
- ISIN
- US68236X1000
- CUSIP
- 68236X100
- CIK
- 1799191
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Dr. Daniel Virnich FACHE, M.B.A., M.D.
- Employee Count
- -
- Website
- https://theoncologyinstitute.com
- Ipo Date
- 2020-06-04
- Details
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
More Stocks
-
PMV
-
MTWOM2i Global, Inc.
MTWO
-
VMUKVirgin Money UK PLC
VMUK
-
GBNXFGibson Energy Inc.
GBNXF
-
RWC
-
SEQI
-
7363baby calendar Inc.
7363
-
1905